Alume Biosciences

Alume Biosciences is a biotechnology company dedicated to developing neurotargeted drugs for surgical and therapeutic uses. The company's first product, ALM-488, is a fluorescently labeled peptide-dye conjugate that can make human nerves "glow," helping surgeons reduce damage to critical nerves during surgery. Unintentional nerve damage during surgery can lead to loss of function, including paralysis, numbness, and reduced quality of life. Alume plans to develop drugs, including ALM-488, as adjuncts to surgery, helping doctors better visualize nerves compared to the current use of white light alone. Alume's technology has the potential to improve the accuracy of nerve identification, reduce surgical time, and deliver better outcomes for patients.